Trial intelligence / Profile preview

Fruquintinib for advanced/recurrent endometrial cancer (real-world, single-arm phase 4 study)

ChiCTR2600123879Phase 4Recruiting

Sponsor

Shanghai Tenth People's Hospital

Start

Apr 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1